vs
LINDSAY CORP（LNN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
LINDSAY CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的2.0倍（$150.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -6.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-15.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.3%）
林赛公司总部位于美国内布拉斯加州奥马哈市，原名林赛制造公司，核心产品为旗下Zimmatic品牌中心枢轴灌溉系统，此外还生产农业机械、工程机械，以及公路与铁路基础设施设备。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LNN vs PBYI — 直观对比
营收规模更大
LNN
是对方的2.0倍
$75.5M
营收增速更快
PBYI
高出33.9%
-6.1%
自由现金流更多
PBYI
多$29.5M
$-15.1M
两年增速更快
PBYI
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.7M | $75.5M |
| 净利润 | $16.5M | — |
| 毛利率 | 33.3% | 69.3% |
| 营业利润率 | 13.0% | 22.7% |
| 净利率 | 11.0% | — |
| 营收同比 | -6.1% | 27.7% |
| 净利润同比 | -3.7% | — |
| 每股收益（稀释后） | $1.54 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNNPBYI
| Q4 25 | $150.7M | $75.5M | ||
| Q3 25 | $149.0M | $54.5M | ||
| Q2 25 | $165.7M | $52.4M | ||
| Q1 25 | $183.8M | $46.0M | ||
| Q4 24 | $160.5M | $59.1M | ||
| Q3 24 | $149.4M | $80.5M | ||
| Q2 24 | $133.7M | $47.1M | ||
| Q1 24 | $146.8M | $43.8M |
净利润LNNPBYI
| Q4 25 | $16.5M | — | ||
| Q3 25 | $10.8M | $8.8M | ||
| Q2 25 | $19.5M | $5.9M | ||
| Q1 25 | $26.6M | $3.0M | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $12.7M | $20.3M | ||
| Q2 24 | $20.4M | $-4.5M | ||
| Q1 24 | $18.1M | $-4.8M |
毛利率LNNPBYI
| Q4 25 | 33.3% | 69.3% | ||
| Q3 25 | 30.0% | 77.7% | ||
| Q2 25 | 32.4% | 76.5% | ||
| Q1 25 | 34.0% | 77.1% | ||
| Q4 24 | 31.1% | 76.4% | ||
| Q3 24 | 30.6% | 63.9% | ||
| Q2 24 | 34.8% | 77.4% | ||
| Q1 24 | 33.3% | 75.5% |
营业利润率LNNPBYI
| Q4 25 | 13.0% | 22.7% | ||
| Q3 25 | 7.6% | 17.6% | ||
| Q2 25 | 14.4% | 12.7% | ||
| Q1 25 | 17.5% | 8.7% | ||
| Q4 24 | 13.0% | 22.6% | ||
| Q3 24 | 9.0% | 27.4% | ||
| Q2 24 | 14.9% | -4.6% | ||
| Q1 24 | 15.1% | -5.3% |
净利率LNNPBYI
| Q4 25 | 11.0% | — | ||
| Q3 25 | 7.3% | 16.2% | ||
| Q2 25 | 11.8% | 11.2% | ||
| Q1 25 | 14.5% | 6.5% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 8.5% | 25.2% | ||
| Q2 24 | 15.2% | -9.6% | ||
| Q1 24 | 12.3% | -11.0% |
每股收益（稀释后）LNNPBYI
| Q4 25 | $1.54 | $0.26 | ||
| Q3 25 | $0.99 | $0.17 | ||
| Q2 25 | $1.78 | $0.12 | ||
| Q1 25 | $2.44 | $0.06 | ||
| Q4 24 | $1.57 | $0.40 | ||
| Q3 24 | $1.16 | $0.41 | ||
| Q2 24 | $1.85 | $-0.09 | ||
| Q1 24 | $1.64 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.6M | $97.5M |
| 总债务越低越好 | $115.2M | $22.7M |
| 股东权益账面价值 | $518.2M | $130.3M |
| 总资产 | $828.4M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.22× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LNNPBYI
| Q4 25 | $199.6M | $97.5M | ||
| Q3 25 | $250.6M | $94.4M | ||
| Q2 25 | $210.8M | $96.0M | ||
| Q1 25 | $186.7M | $93.2M | ||
| Q4 24 | $194.1M | $101.0M | ||
| Q3 24 | $190.9M | $96.7M | ||
| Q2 24 | $152.7M | $96.8M | ||
| Q1 24 | $150.6M | $107.2M |
总债务LNNPBYI
| Q4 25 | $115.2M | $22.7M | ||
| Q3 25 | $115.3M | $34.0M | ||
| Q2 25 | $115.3M | $45.3M | ||
| Q1 25 | $115.4M | $56.7M | ||
| Q4 24 | $115.4M | $68.0M | ||
| Q3 24 | $115.5M | $79.3M | ||
| Q2 24 | $115.5M | $90.7M | ||
| Q1 24 | $115.6M | $102.0M |
股东权益LNNPBYI
| Q4 25 | $518.2M | $130.3M | ||
| Q3 25 | $532.9M | $115.3M | ||
| Q2 25 | $528.8M | $104.7M | ||
| Q1 25 | $516.4M | $97.1M | ||
| Q4 24 | $488.5M | $92.1M | ||
| Q3 24 | $480.9M | $71.1M | ||
| Q2 24 | $480.0M | $48.5M | ||
| Q1 24 | $483.0M | $51.0M |
总资产LNNPBYI
| Q4 25 | $828.4M | $216.3M | ||
| Q3 25 | $840.8M | $202.9M | ||
| Q2 25 | $840.9M | $194.9M | ||
| Q1 25 | $814.2M | $196.2M | ||
| Q4 24 | $771.0M | $213.3M | ||
| Q3 24 | $760.2M | $220.7M | ||
| Q2 24 | $758.1M | $205.0M | ||
| Q1 24 | $765.3M | $214.1M |
负债/权益比LNNPBYI
| Q4 25 | 0.22× | 0.17× | ||
| Q3 25 | 0.22× | 0.30× | ||
| Q2 25 | 0.22× | 0.43× | ||
| Q1 25 | 0.22× | 0.58× | ||
| Q4 24 | 0.24× | 0.74× | ||
| Q3 24 | 0.24× | 1.12× | ||
| Q2 24 | 0.24× | 1.87× | ||
| Q1 24 | 0.24× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-597.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-15.1M | $14.4M |
| 自由现金流率自由现金流/营收 | -10.0% | 19.1% |
| 资本支出强度资本支出/营收 | 9.6% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.04× | — |
| 过去12个月自由现金流最近4个季度 | $62.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LNNPBYI
| Q4 25 | $-597.0K | $14.4M | ||
| Q3 25 | $64.0M | $9.7M | ||
| Q2 25 | $35.0M | $14.1M | ||
| Q1 25 | $12.3M | $3.6M | ||
| Q4 24 | $21.6M | $15.6M | ||
| Q3 24 | $53.1M | $11.0M | ||
| Q2 24 | $30.5M | $1.0M | ||
| Q1 24 | $-9.7M | $11.2M |
自由现金流LNNPBYI
| Q4 25 | $-15.1M | $14.4M | ||
| Q3 25 | $49.8M | $9.7M | ||
| Q2 25 | $25.7M | $14.1M | ||
| Q1 25 | $2.5M | $3.6M | ||
| Q4 24 | $12.5M | $15.6M | ||
| Q3 24 | $47.7M | $11.0M | ||
| Q2 24 | $25.8M | $1.0M | ||
| Q1 24 | $-21.6M | — |
自由现金流率LNNPBYI
| Q4 25 | -10.0% | 19.1% | ||
| Q3 25 | 33.4% | 17.7% | ||
| Q2 25 | 15.5% | 26.8% | ||
| Q1 25 | 1.4% | 7.7% | ||
| Q4 24 | 7.8% | 26.4% | ||
| Q3 24 | 31.9% | 13.7% | ||
| Q2 24 | 19.3% | 2.1% | ||
| Q1 24 | -14.7% | — |
资本支出强度LNNPBYI
| Q4 25 | 9.6% | 0.0% | ||
| Q3 25 | 9.6% | 0.0% | ||
| Q2 25 | 5.6% | 0.0% | ||
| Q1 25 | 5.3% | 0.1% | ||
| Q4 24 | 5.7% | 0.0% | ||
| Q3 24 | 3.6% | 0.0% | ||
| Q2 24 | 3.6% | 0.0% | ||
| Q1 24 | 8.1% | 0.0% |
现金转化率LNNPBYI
| Q4 25 | -0.04× | — | ||
| Q3 25 | 5.92× | 1.10× | ||
| Q2 25 | 1.79× | 2.41× | ||
| Q1 25 | 0.46× | 1.21× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 4.17× | 0.54× | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | -0.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNN
| Transferred At Point In Time | $133.2M | 88% |
| Infrastructure | $13.4M | 9% |
| Transferred Over Time | $8.0M | 5% |
PBYI
暂无分部数据
